With the inflation of prescriptions for glucagon-like peptide-1 receptor agonists like Ozempic, Mounjaro and Wegovy, physicians began seeing a startling amount of regurgitation and aspiration in ...
Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...
A new type of PrEP injection, requiring only three injections a year, could be on the way. The FDA approved injections of cabotegravir in 2021 as a form of PrEP, to minimize the risk of acquiring HIV.
A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback